Literature DB >> 8581856

The clinical manifestations of bovine viral diarrhea infection.

J C Baker1.   

Abstract

BVDV infections may result in a wide range of clinical manifestations ranging from subclinical infections to a severe, highly fatal form referred to as MD. In recent years, a better understanding of pathogenesis has been achieved that has allowed for a better understanding of the different clinical forms of BVDV infection. Knowledge in this area continues to evolve. The clinical forms of BVDV infections are best understood by breaking them into categories that include infections in immunocompetent cattle, fetal infections, and infections in cattle that are immunotolerant to BVDV.

Entities:  

Mesh:

Year:  1995        PMID: 8581856     DOI: 10.1016/s0749-0720(15)30460-6

Source DB:  PubMed          Journal:  Vet Clin North Am Food Anim Pract        ISSN: 0749-0720            Impact factor:   3.357


  100 in total

1.  Bovine viral diarrhea viral infections in feeder calves with respiratory disease: interactions with Pasteurella spp., parainfluenza-3 virus, and bovine respiratory syncytial virus.

Authors:  R W Fulton; C W Purdy; A W Confer; J T Saliki; R W Loan; R E Briggs; L J Burge
Journal:  Can J Vet Res       Date:  2000-07       Impact factor: 1.310

2.  Hobi-like pestivirus in aborted bovine fetuses.

Authors:  Nicola Decaro; Maria Stella Lucente; Viviana Mari; Rossana Sciarretta; Pierfrancesco Pinto; Domenico Buonavoglia; Vito Martella; Canio Buonavoglia
Journal:  J Clin Microbiol       Date:  2011-12-07       Impact factor: 5.948

3.  Challenge with Bovine viral diarrhea virus by exposure to persistently infected calves: protection by vaccination and negative results of antigen testing in nonvaccinated acutely infected calves.

Authors:  Robert W Fulton; Bill J Johnson; Robert E Briggs; Julia F Ridpath; Jeremiah T Saliki; Anthony W Confer; Lurinda J Burge; Douglas L Step; Derek A Walker; Mark E Payton
Journal:  Can J Vet Res       Date:  2006-04       Impact factor: 1.310

4.  The effects of cytopathic and noncytopathic bovine viral diarrhoea virus with sperm cells on in vitro fertilization of bovine oocytes.

Authors:  M Talebkhan Garoussi
Journal:  Vet Res Commun       Date:  2006-12-23       Impact factor: 2.459

5.  Evaluation of the serum virome in calves persistently infected with Pestivirus A, presenting or not presenting mucosal disease.

Authors:  Matheus N Weber; Samuel P Cibulski; Simone Silveira; Franciele M Siqueira; Ana Cristina S Mósena; Mariana S da Silva; Juliana C Olegário; Ana Paula M Varela; Thaís F Teixeira; Matheus V Bianchi; David Driemeier; Saulo P Pavarini; Fabiana Q Mayer; Paulo M Roehe; Cláudio W Canal
Journal:  Virus Genes       Date:  2018-09-14       Impact factor: 2.332

6.  A survey of vaccination practices against bovine viral diarrhea (BVD) virus in Saskatchewan dairy herds.

Authors:  T D Carruthers; L Petrie
Journal:  Can Vet J       Date:  1996-10       Impact factor: 1.008

7.  Expression of a 50 kDa putative receptor for bovine viral diarrhea virus in bovine fetal tissues.

Authors:  L Zheng; S Zhang; W Xue; S Kapil; H C Minocha
Journal:  Can J Vet Res       Date:  1998-04       Impact factor: 1.310

8.  Increased genetic diversity of BVDV strains circulating in Eastern Anatolia, Turkey: first detection of BVDV-3 in Turkey.

Authors:  Mehmet Özkan Timurkan; Hakan Aydın
Journal:  Trop Anim Health Prod       Date:  2019-05-04       Impact factor: 1.559

9.  Bovine viral diarrhea virus (BVDV) 1b: predominant BVDV subtype in calves with respiratory disease.

Authors:  Robert W Fulton; Julia F Ridpath; Jeremiah T Saliki; Robert E Briggs; Anthony W Confer; Lurinda J Burge; C W Purdy; Raymond W Loan; Glenn C Duff; Mark E Payton
Journal:  Can J Vet Res       Date:  2002-07       Impact factor: 1.310

10.  A single vaccination with an inactivated bovine respiratory syncytial virus vaccine primes the cellular immune response in calves with maternal antibody.

Authors:  Mirjam T W van der Sluijs; Eva M Kuhn; Birgit Makoschey
Journal:  BMC Vet Res       Date:  2010-01-11       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.